Bibliography 2004

Thyroid disease in northern Italian children born around the time of the Chernobyl nuclear accident. 
Chiesa F, Tradati N, Calabrese L, Gibelli B, Giugliano G, Paganelli G, De Cicco C, Grana C, Tosi G, DeFiori E, Cammarano G, Cusati A, Zurrida S. 
Ann Oncol. 2004 Dec;15(12):1842-6.

Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French thyroid cancer committee. 
Leenhardt L, Grosclaude P, Cherie-Challine L. 
Thyroid. 2004 Dec;14(12):1056-60. 

Increase of regional total cancer incidence in north Sweden due to the Chernobyl accident? 
Tondel M, Hjalmarsson P, Hardell L, Carlsson G, Axelson O. 
J Epidemiol Community Health. 2004 Dec;58(12):1011-6. 

Projecting the time trend of thyroid cancers: its impact on assessment of radiation-induced cancer risks. 
Catelinois O, Verger P, Colonna M, Rogel A, Hemon D, Tirmarche M. 
Health Phys. 2004 Dec;87(6):606-14. 

[Thyroid cancer in Poland in 1980-2000] 
Przegl Epidemiol. 2004;58(2):369-76. 
Roszkowska H, Gorynski P. 

Time trends of thyroid cancer incidence in Ukraine after the Chernobyl accident. 
J Radiol Prot. 2004 Sep;24(3):283-93. 
Heidenreich WF, Bogdanova TI, Biryukov AG, Tronko ND. 

Clinical Analysis of Thyroid Cancer in Adult Patients Exposed to Ionizing Radiation due to the Chernobyl Nuclear Accident: 5-Year Comparative Investigations Based on the Results of Surgical Treatment. 
World J Surg. 2004 Oct 21; [Epub ahead of print] 
Cherenko SM, Larin OS, Gorobeyko MB, Sichynava RM. 

Radioiodine and thyroid carcinoma: KI prophylaxis in children. 
Acta Biomed Ateneo Parmense. 2004 Aug;75(2):I-XIII. 
Giovannelli G. 

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. 
J Clin Endocrinol Metab. 2004 Sep;89(9):4280-4. 
Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y, Yamashita S. 

Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. 
J Clin Endocrinol Metab. 2004 Sep;89(9):4272-9. 
Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, Thomas G. 

BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. 
J Clin Endocrinol Metab. 2004 Sep;89(9):4267-71. 
Lima J, Trovisco V, Soares P, Maximo V, Magalhaes J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simoes M. 

Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. 
Radiat Res. 2004 Sep;162(3):241-8. 
Davis S, Stepanenko V, Rivkind N, Kopecky KJ, Voilleque P, Shakhtarin V, Parshkov E, Kulikov S, Lushnikov E, Abrosimov A, Troshin V, Romanova G, Doroschenko V, Proshin A, Tsyb A. 

Thyroid cancer has increased in the adult populations of countries moderately affected by Chernobyl fallout. 
Med Sci Monit. 2004 Jul;10(7):CR300-6. 
Murbeth S, Rousarova M, Scherb H, Lengfelder E. 

[Surgical treatment of sporadic and radiation-induced thyroid cancer in young patients] 
Vestn Khir Im I I Grek. 2004;163(2):75-8. 
Romanchishen AF, Cheren'ko SM, Gostimskii AV, Larin AS. 

The long-term management of nuclear emergencies: the principles.
Baverstock K, Cherp A, Gray P.
Radiat Prot Dosimetry. 2004;109(1-2):3-5.

Thyroid cancer has increased in the adult populations of countries moderately affected by Chernobyl fallout.
Murbeth S, Rousarova M, Scherb H, Lengfelder E.
Med Sci Monit. 2004 Jul;10(7):CR300-6. Epub 2004 Jun 29.

Iodine toxicity and its amelioration. 
Baker DH. 
Exp Biol Med (Maywood). 2004 Jun;229(6):473-8. 

Individual thyroid dose estimation for a case-control study of Chernobyl-related thyroid cancer among children of Belarus-part I: 131I, short-lived radioiodines (132I, 133I, 135I), and short-lived radiotelluriums (131MTe and 132Te). 
Gavrilin Y, Khrouch V, Shinkarev S, Drozdovitch V, Minenko V, Shemiakina E, Ulanovsky A, Bouville A, Anspaugh L, Voilleque P, Luckyanov N. 
Health Phys. 2004 Jun;86(6):565-85. 

Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. 
Mahoney MC, Lawvere S, Falkner KL, Averkin YI, Ostapenko VA, Michalek AM, Moysich KB, McCarthy PL. 
Int J Epidemiol. 2004 May 27 [Epub ahead of print]

Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. 
Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, LiVolsi V, Lushnikov E, Rosai J, Sidorov Y, Tronko MD, Tsyb AF, Vowler SL, Thomas GA. 
Br J Cancer. 2004 Jun 1;90(11):2219-24.

[In Process Citation] 
No authors listed 
Tsitol Genet. 2004 Jan-Feb;38(1):9-14. 

Dose response for T-cell receptor (TCR) mutants in patients repeatedly treated with 131I for thyroid cancer. 
Vershenya S, Biko J, Drozd V, Lorenz R, Reiners C, Hempel K. 
Mutat Res. 2004 Apr 14;548(1-2):27-33. 

A review of thyroid cancer with intermediate differentiation. 
Sywak M, Pasieka JL, Ogilvie T. 
J Surg Oncol. 2004 Apr 1;86(1):44-54. 

BRAF T1796A transversion mutation in various thyroid neoplasms. 
Xing M, Vasko V, Tallini G, Larin A, Wu G, Udelsman R, Ringel MD, Ladenson PW, Sidransky D. 
J Clin Endocrinol Metab. 2004 Mar;89(3):1365-8. 

Estimating individual thyroid doses for a case-control study of childhood thyroid cancer in Bryansk Oblast, Russia. 
Stepanenko VF, Voilleque PG, Gavrilin YI, Khrouch VT, Shinkarev SM, Orlov MY, Kondrashov AE, Petin DV, Iaskova EK, Tsyb AF. 
Radiat Prot Dosimetry. 2004;108(2):143-60. 

A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster. 
Niedziela M, Korman E, Breborowicz D, Trejster E, Harasymczuk J, Warzywoda M, Rolski M, Breborowicz J. 
Pediatr Blood Cancer. 2004 Jan;42(1):84-92.